Provided by Tiger Trade Technology Pte. Ltd.

Progyny

20.36
+0.01000.05%
Post-market: 20.360.00000.00%17:16 EST
Volume:1.18M
Turnover:24.04M
Market Cap:1.76B
PE:32.98
High:20.66
Open:20.34
Low:20.14
Close:20.35
52wk High:28.75
52wk Low:17.98
Shares:86.21M
Float Shares:79.60M
Volume Ratio:0.84
T/O Rate:1.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6173
EPS(LYR):0.5700
ROE:11.37%
ROA:7.37%
PB:3.13
PE(LYR):35.72

Loading ...

Progyny Inc. to Report Quarterly and Full Year Financial Results

Reuters
·
Feb 13

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report

GlobeNewswire
·
Feb 13

Analysts Offer Insights on Healthcare Companies: Palvella Therapeutics (PVLA) and Progyny (PGNY)

TIPRANKS
·
Feb 09

Is Progyny (PGNY) Pricing Reflect Future Growth After Recent Share Price Weakness

Simply Wall St.
·
Feb 01

Progyny Inc : Btig Raises Target Price to $35 From $30

THOMSON REUTERS
·
Jan 21

Progyny Raised to Market Outperform From Market Perform by Citizens

Dow Jones
·
Jan 20

Progyny upgraded to Outperform from Market Perform at Citizens

TIPRANKS
·
Jan 20

Progyny Inc. Highlights Client Growth and Cost Management in Latest Corporate Presentation

Reuters
·
Jan 14

BRIEF-Progyny Inc Anticipates Q4 And Full Year Results To Be Slightly Above Previously Provided Financial Guidance

Reuters
·
Jan 12

Progyny Expects Q4 and Full-Year Results to Exceed Prior Guidance

Reuters
·
Jan 12

Press Release: Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference

Dow Jones
·
Jan 12

Assessing Progyny (PGNY) Valuation After Keybanc Upgrade And Strong Fertility Benefits Demand

Simply Wall St.
·
Jan 10

Progyny Is Maintained at Overweight by Keybanc

Dow Jones
·
Jan 08

KeyBanc Remains a Buy on Progyny (PGNY)

TIPRANKS
·
Jan 08

Leadership Reshuffle Without a Successor Might Change The Case For Investing In Progyny (PGNY)

Simply Wall St.
·
Dec 22, 2025

Progyny Inc. Awards $250,000 Annual Advisory Fee to Outgoing President Under New Consulting Agreement

Reuters
·
Dec 17, 2025

Progyny CFO Mark S. Livingston Reports Sale of Common Shares

Reuters
·
Dec 16, 2025

Progyny Initiated at Overweight by Barclays

Dow Jones
·
Dec 10, 2025

Progyny Inc. EVP and General Counsel Allison Swartz Reports Disposal of Common Shares

Reuters
·
Dec 09, 2025

Has Progyny’s 62.7% Surge Outrun Its Fundamentals in 2025?

Simply Wall St.
·
Dec 06, 2025